Words of wisdom. Re: Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection. Lotan Y, Shariat SF; NMP22 Study Group. BJU Int 2008;101:1362-7.
Svatek
Robert S
RS
MD Anderson Cancer Center, Urologic Oncology, 1515 Holcombe, Unit 1373, Houston, TX 77030, USA. rssvatek@sbcglobal.net
Dinney
Colin P
CP